Skip to content
Tenfell
Awarded contract
Published 27 Aug 2025

Commercial Kit for screening for hereditary tyrosinemia type 1 (HT1)

NHS England · London

Key facts

Contract value
£1,677,290
Awarded
30 Mar 2025
Contract starts
31 Mar 2025
Contract ends
31 Mar 2027
Procedure
Call-off from a framework agreement (framework)
Buyer type
Central government

Awarded to

SupplierValue
PerkinElmer LAS (UK) Limited£1,677,290

Description

Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions. The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card. The blood sample is analysed by one of 13 newborn screening laboratories in England

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder (Open Government Licence v3.0). Always read the original notice before responding.